BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33677674)

  • 41. Antithrombin III infusion suppresses the hypercoagulable state in adult acute lymphoblastic leukaemia patients treated with a low dose of Escherichia coli L-asparaginase. A GIMEMA study.
    Mazzucconi MG; Gugliotta L; Leone G; Dragoni F; Belmonte MM; De Stefano V; Chistolini A; Tura S; Mandelli F
    Blood Coagul Fibrinolysis; 1994 Feb; 5(1):23-8. PubMed ID: 7514043
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Erwinia- and E. coli-derived L-asparaginase have similar effects on hemostasis. Pilot study in 10 patients with acute lymphoblastic leukemia.
    Castaman G; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):57-60. PubMed ID: 8039761
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of PEG-asparaginase in newly diagnosed adults with standard-risk acute lymphoblastic leukemia compared with E. coli-asparaginase: a retrospective single-center study.
    Liu WJ; Wang H; Wang WD; Zhu MY; Liu CC; Wang JH; Lu Y
    Sci Rep; 2016 Dec; 6():39463. PubMed ID: 28000713
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Efficacy observation of polyethylene glycol conjugated asparaginase for induction treatment of children with newly diagnosed acute lymphoblastic leukemia].
    Liu F; Wan Y; Chang L; Guo Y; Yang W; Wang S; Chen X; Liu T; Ruan M; Zhang L; Liu X; Zou Y; Chen Y; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):215-7. PubMed ID: 24824393
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology (NOPHO) study.
    Tuckuviene R; Ranta S; Albertsen BK; Andersson NG; Bendtsen MD; Frisk T; Gunnes MW; Helgestad J; Heyman MM; Jonsson OG; Mäkipernaa A; Pruunsild K; Tedgård U; Trakymiene SS; Ruud E
    J Thromb Haemost; 2016 Mar; 14(3):485-94. PubMed ID: 26707629
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years.
    Rank CU; Toft N; Tuckuviene R; Grell K; Nielsen OJ; Frandsen TL; Marquart HVH; Albertsen BK; Tedgård U; Hallböök H; Ruud E; Jarvis KB; Quist-Paulsen P; Huttunen P; Wartiovaara-Kautto U; Jónsson ÓG; Trakymiene SS; Griškevičius L; Saks K; Punab M; Schmiegelow K
    Blood; 2018 May; 131(22):2475-2484. PubMed ID: 29661787
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adequate asparaginase is important to prevent central nervous system and testicular relapse of pediatric Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia.
    Liu C; Huang B; Wu R; Chen J; Tang Y; Hu W; Li J; Chen X; Cai J; Zhou M; Chen C; Shen S
    Int J Cancer; 2021 Jul; 149(1):158-168. PubMed ID: 33634856
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Peg-asparaginase for acute lymphoblastic leukemia.
    Rytting M
    Expert Opin Biol Ther; 2010 May; 10(5):833-9. PubMed ID: 20345338
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Incidence of venous thrombosis after peg-asparaginase in adolescent and young adults with acute lymphoblastic leukemia.
    Underwood B; Zhao Q; Walker AR; Mims AS; Vasu S; Long M; Z Haque T; Blaser BW; Grieselhuber NR; Wall SA; Behbehani GK; Blachly JS; Larkin K; Byrd JC; Garzon R; Wang TF; Bhatnagar B
    Int J Hematol Oncol; 2020 Sep; 9(3):IJH28. PubMed ID: 33014332
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pegaspargase-induced hypertriglyceridemia in a patient with acute lymphoblastic leukemia.
    Lau KM; Saunders IM; Goodman A
    J Oncol Pharm Pract; 2020 Jan; 26(1):193-199. PubMed ID: 30823860
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cerebrovascular complications of L-asparaginase in the therapy of acute lymphoblastic leukemia.
    Kieslich M; Porto L; Lanfermann H; Jacobi G; Schwabe D; Böhles H
    J Pediatr Hematol Oncol; 2003 Jun; 25(6):484-7. PubMed ID: 12794528
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety profile of asparaginase Erwinia chrysanthemi in a large compassionate-use trial.
    Plourde PV; Jeha S; Hijiya N; Keller FG; Silverman LB; Rheingold SR; Dreyer ZE; Dahl GV; Mercedes T; Lai C; Corn T
    Pediatr Blood Cancer; 2014 Jul; 61(7):1232-8. PubMed ID: 24436152
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thrombosis associated with L-asparaginase therapy and low fibrinogen levels in adult acute lymphoblastic leukemia.
    Beinart G; Damon L
    Am J Hematol; 2004 Dec; 77(4):331-5. PubMed ID: 15551293
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence and Risk Factors of Venous Thromboembolism in Childhood Acute Lymphoblastic Leukaemia - a Population-Based Analysis of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group.
    Gidl A; Füreder A; Benesch M; Dworzak M; Engstler G; Jones N; Kropshofer G; Pötschger U; Poyer F; Tamesberger M; Witt V; Mann G; Attarbaschi A;
    Pediatr Hematol Oncol; 2023 Mar; 40(2):181-191. PubMed ID: 35848787
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Successful treatment with apixaban of sinus venous thrombosis due to pegylated asparaginase in a young adult with T cell acute lymphoblastic leukemia: case report and review of management.
    Talamo L; Douvas M; Macik BG; Ornan D
    Ann Hematol; 2017 Apr; 96(4):691-693. PubMed ID: 28132079
    [No Abstract]   [Full Text] [Related]  

  • 56. Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia.
    Douer D; Yampolsky H; Cohen LJ; Watkins K; Levine AM; Periclou AP; Avramis VI
    Blood; 2007 Apr; 109(7):2744-50. PubMed ID: 17132721
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Asparaginase-related venous thrombosis in UKALL 2003- re-exposure to asparaginase is feasible and safe.
    Qureshi A; Mitchell C; Richards S; Vora A; Goulden N
    Br J Haematol; 2010 May; 149(3):410-3. PubMed ID: 20201945
    [TBL] [Abstract][Full Text] [Related]  

  • 58. FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).
    Dinndorf PA; Gootenberg J; Cohen MH; Keegan P; Pazdur R
    Oncologist; 2007 Aug; 12(8):991-8. PubMed ID: 17766659
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conservative treatment of L-asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia.
    Cohen H; Bielorai B; Harats D; Toren A; Pinhas-Hamiel O
    Pediatr Blood Cancer; 2010 May; 54(5):703-6. PubMed ID: 20063421
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of anti-asparaginase antibodies during therapy with E.coli asparaginase in children with newly diagnosed acute lymphoblastic leukemia and lymphoma.
    Ebeid EN; Kamel MM; Ali BA
    J Egypt Natl Canc Inst; 2008 Jun; 20(2):127-33. PubMed ID: 20029468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.